Replies to post #1726 on Conatus Pharmaceuticals Inc. (CNAT)

[fishhunter]

I just don't understand why the stock refuses to make any sort of move higher. CNAT should be sitting at $12 to $15 now and then double from there if first Ph2 results are encouraging. Yet we are at $5, a price not too different than a couple years ago pre-Novartis. Frustrating.

[Rogerthat1]

Yes. Roth will sell shares into any strength. Imo. Still like the story here